Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.2374
-0.0041 (-1.70%)
At close: May 18, 2026, 4:00 PM EDT
0.2374
0.00 (0.00%)
After-hours: May 18, 2026, 4:52 PM EDT
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of $37.89 million as of May 18, 2026. Its market cap has decreased by -90.83% in one year.
Market Cap
37.89M
Enterprise Value
1.67M
1-Year Change
-90.83%
Ranking
Category
Stock Price
$0.24
Market Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has decreased from $124.83M to $37.89M, a decrease of -69.65%. That is a compound annual growth rate of -15.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 38.55M | -41.87% |
| Dec 31, 2025 | 66.31M | -87.77% |
| Dec 31, 2024 | 542.14M | 67.64% |
| Dec 29, 2023 | 323.39M | 269.38% |
| Dec 30, 2022 | 87.55M | -49.64% |
| Dec 31, 2021 | 173.85M | -28.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lite Strategy | 42.54M |
| Atossa Therapeutics | 41.77M |
| INmune Bio | 41.21M |
| Quantum BioPharma | 39.31M |
| Actinium Pharmaceuticals | 38.97M |
| Tvardi Therapeutics | 37.53M |
| RenovoRx | 36.94M |
| Plus Therapeutics | 36.03M |